|
1
|
Rosen J and Miner JN: The search for safer
glucocorticoid receptor ligands. Endocr Rev. 26:452–464. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kofler R: The molecular basis of
glucocorticoid-induced apoptosis of lymphoblastic leukemia cells.
Histochem Cell Biol. 114:1–7. 2000.PubMed/NCBI
|
|
3
|
Evans-Storms RB and Cidlowski JA:
Delineation of an anti-apoptotic action of glucocorticoids in
hepatoma cells: the role of nuclear factor-kappaB. Endocrinology.
141:1854–1862. 2000.PubMed/NCBI
|
|
4
|
Bernard-Marty C, Cardoso F and Piccart MJ:
Use and abuse of taxanes in the management of metastatic breast
cancer. Eur J Cancer. 39:1978–1989. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang C, Beckermann B, Kallifatidis G, Liu
Z, Rittgen W, Edler L, Büchler P, Debatin KM, Büchler MW, Friess H
and Herr I: Corticosteroids induce chemotherapy resistance in the
majority of tumour cells from bone, brain, breast, cervix, melanoma
and neuroblastoma. Int J Oncol. 29:1295–1301. 2006.PubMed/NCBI
|
|
6
|
Moutsatsou P and Papavassiliou AG: The
glucocorticoid receptor signalling in breast cancer. J Cell Mol
Med. 12:145–163. 2008. View Article : Google Scholar
|
|
7
|
Beato M, Herrlich P and Schütz G: Steroid
hormone receptors: many actors in search of a plot. Cell.
83:851–857. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arbyn M, Autier P and Ferlay J: Burden of
cervical cancer in the 27 member states of the European Union:
estimates for 2004. Ann Oncol. 18:1423–1425. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sørensen GV, Cronin-Fenton DP, Sørensen
HT, Ulrichsen SP, Pedersen L and Lash TL: Use of glucocorticïds and
risk of breast cancer: a Danish population-based case-control
study. Breast Cancer Res. 14:R212012. View
Article : Google Scholar
|
|
10
|
Gong H, Jarzynka MJ, Cole TJ, Lee JH, Wada
T, Zhang B, Gao J, Song WC, DeFranco DB, Cheng SY and Xie W:
Glucocorticoids antagonize estrogens by glucocorticoid
receptor-mediated activation of estrogen sulfotransferase. Cancer
Res. 68:7386–7393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Skor MN, Wonder EL, Kocherginsky M, Goyal
A, Hall BA, Cai Y and Conzen SD: Glucocorticoid receptor antagonism
as a novel therapy for triple-negative breast cancer. Clin Cancer
Res. 19:6163–6172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lien HC, Lu YS, Cheng AL, Chang WC, Jeng
YM, Kuo YH, Huang CS, Chang KJ and Yao YT: Differential expression
of glucocorticoid receptor in human breast tissues and related
neoplasms. J Pathol. 209:317–327. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Buxant F, Engohan-Aloghe C and Noël JC:
Estrogen receptor, progesterone receptor, and glucocorticoid
receptor expression in normal breast tissue, breast in situ
carcinoma, and invasive breast cancer. Appl Immunohistochem Mol
Morphol. 18:254–257. 2010. View Article : Google Scholar
|
|
14
|
Vilasco M, Communal L, Hugon-Rodin J,
Penault-Llorca F, Mourra N, Wu Z, Forgez P and Gompel A; BRACAPS:
Loss of glucocorticoid receptor activation is a hallmark of
BRCA1-mutated breast tissue. Breast Cancer Res Treat. 142:283–296.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Conde I, Paniagua R, Fraile B, Lucio J and
Arenas MI: Glucocorticoid receptor changes its cellular location
with breast cancer development. Histol Histopathol. 23:77–85.
2008.
|
|
16
|
Krishnan AV, Swami S and Feldman D:
Estradiol inhibits glucocorticoid receptor expression and induces
glucocorticoid resistance in MCF-7 human breast cancer cells. J
Steroid Biochem Mol Biol. 77:29–37. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Govindan MV, Devic M, Green S, Gronemeyer
H and Chambon P: Cloning of the human glucocorticoid receptor cDNA.
Nucleic Acids Res. 13:8293–8304. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oakley RH and Cidlowski JA: Cellular
processing of the glucocorticoid receptor gene and protein: new
mechanisms for generating tissue-specific actions of
glucocorticoids. J Biol Chem. 286:3177–3184. 2011. View Article : Google Scholar :
|
|
19
|
Moutsatsou P and Papavassiliou AG: The
glucocorticoid receptor signalling in breast cancer. J Cell Mol
Med. 12:145–163. 2008. View Article : Google Scholar
|
|
20
|
Lippman M, Bolan G and Huff K: The effects
of glucocorticoids and progesterone on hormone-responsive human
breast cancer in long-term tissue culture. Cancer Res.
36:4602–4609. 1976.PubMed/NCBI
|
|
21
|
Huff KK, Knabbe C, Lindsey R, Kaufman D,
Bronzert D, Lippman ME and Dickson RB: Multihormonal regulation of
insulin-like growth factor-I-related protein in MCF-7 human breast
cancer cells. Mol Endocrinol. 2:200–208. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schorr K and Furth PA: Induction of bcl-xL
expression in mammary epithelial cells is glucocorticoid-dependent
but not signal transducer and activator of transcription
5-dependent. Cancer Res. 60:5950–5953. 2000.PubMed/NCBI
|
|
23
|
Wu W, Pew T, Zou M, Pang D and Conzen SD:
Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1)
expression inhibits paclitaxel-associated MAPK activation and
contributes to breast cancer cell survival. J Biol Chem.
280:4117–4124. 2005. View Article : Google Scholar
|
|
24
|
Wu W, Chaudhuri S, Brickley DR, Pang D,
Karrison T and Conzen SD: Microarray analysis reveals
glucocorticoid-regulated survival genes that are associated with
inhibition of apoptosis in breast epithelial cells. Cancer Res.
64:1757–1764. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Li M, Rinehart JJ and Zhang R:
Dexamethasone as a chemoprotectant in cancer chemotherapy:
hematoprotective effects and altered pharmacokinetics and tissue
distribution of carboplatin and gemcitabine. Cancer Chemother
Pharmacol. 53:459–467. 2004. View Article : Google Scholar : PubMed/NCBI
|
